Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Expert panel – Dr Georgia Rigas & A/Prof Samantha Hocking, facilitated by Dr Angela Kwong
Weight Management in Women of Reproductive Age
Jarrod Warner & Irene Schneider
New Spirometry Standards: Key Changes for Clinical Practice
A/Prof Alberto Pinzon Charry
Food Allergy Prevention
A/Prof Daryl Cheng
Protecting Young Lungs – Paediatric Insights into RSV
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
